Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Growth Rate of the Nuclear Medicine Diagnostics Market?

In recent times, the market size for nuclear medicine diagnostics has experienced rapid expansion. Anticipated growth forecasts suggest an increase from $7.16 billion in 2024 to $7.94 billion in 2025, representing a compound annual growth rate (CAGR) of 11.0%. This substantial increase during the historic period is a result of factors such as advancements in the field of medical imaging, a rise in chronic diseases, an aging demographic pattern, oncology-related clinical applications, as well as the precision and accuracy of diagnostics.

What Growth Rate Is Forecasted for the Nuclear Medicine Diagnostics Market by 2029?

The market for nuclear medicine diagnostics is projected to experience swift expansion in the coming years, growing at a compound annual growth rate (CAGR) of 12.1% to reach $12.56 billion in 2029. This anticipated growth over the forecast period can be linked to the increasing utilization in neurology, amalgamation with other imaging techniques, the rising popularity of precision medicine methods, the heightened demand for theranostics, and worldwide initiatives toward disease elimination. Key trends expected in the forecast period encompass a shift towards compact, local radiopharmacy, the usage of nuclear medicine in neurology, radiomics and analytical imaging, partnerships aimed at research and development, with an increased focus on radiation safety and dosimetry.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9415&type=smp

Which Key Companies Are Shaping the Future of the Nuclear Medicine Diagnostics Market?

Major companies operating in the nuclear medicine diagnostics market include Siemens AG, Bayer Aktiengesellschaft, Novartis AG, GE Healthcare Technologies Inc., Perkin Elmer Inc., Mallinckrodt Pharmaceuticals, Bracco Diagnostics Inc., Lantheus Holdings Inc., IBA Radiopharma Solutions, Curium SAS, Cardinal Health Inc., Eckert & Ziegler Strahlen- und Medizintechnik AG, Advanced Accelerator Applications, Telix Pharmaceuticals Limited, Nordion (Canada) Inc., NorthStar Medical Technologies LLC, SHINE Medical Technologies LLC, Navidea Biopharmaceuticals Inc., Cyclopharm Limited, Isologic Innovative Radiopharmaceuticals, Clarity Pharmaceuticals Limited, Actinium Pharmaceuticals Inc., Jubilant DraxImage Inc., PharmaLogic Holdings Corp, Institute of Isotopes Co Ltd., Global Medical Solutions LLC, Theragnostics Ltd., Eczacibasi-Monrol Nuclear Products Co.

Which Factors Are Driving Demand in the Nuclear Medicine Diagnostics Industry?

The mounting need for nuclear medicine diagnostics is anticipated to fuel the expansion of the nuclear medicine diagnostics market in the future. Nuclear medicine employs radioactive substances within the body for disease diagnoses or to target and eliminate diseased or damaged organs and tissue for treatment. The diagnostic applications of nuclear medicine are predominantly in radiation and other lethal treatments. The escalating demand for nuclear medicine diagnostics is due to benefits like precise results and improved treatment decision making. For instance, in April 2022, a report by the World Nuclear Association, an international organization promoting nuclear power based in the UK, specified that the yearly number of nuclear medicine treatments surpasses 40 million, and the requirement for radioisotopes is growing at a pace of up to 5% annually. Moreover, 90% of procedures employing radioisotopes in medicine occur in over 10,000 hospitals worldwide. Hence, the burgeoning demand for nuclear medicine diagnostics is set to boost the growth of the nuclear medicine diagnostics market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=9415&type=smp

How Is the Nuclear Medicine Diagnostics Market Segmented by Several Divisions?

The nuclear medicine diagnostics market covered in this report is segmented –

1) By Type: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals

2) By Application: Cardiology, Thyroid, Neurology, Oncology, Other Applications

3) By End-User: Hospitals And Diagnostic Centers, Research Institutes

Subsegments:

1) By SPECT Radiopharmaceuticals: Technetium-99m-Based Radiopharmaceuticals, Iodine-123-Based Radiopharmaceuticals, Thallium-201-Based Radiopharmaceuticals, Other SPECT Radiopharmaceuticals

2) By PET Radiopharmaceuticals: Fluorine-18-Based Radiopharmaceuticals, Carbon-11-Based Radiopharmaceuticals, Gallium-68-Based Radiopharmaceuticals, Other PET Radiopharmaceuticals

What are the Emerging Market Trends Driving the Growth of the Nuclear Medicine Diagnostics Industry?

Prime corporations within the nuclear medicine diagnostics market are strategizing to introduce superior solutions, such as avant-garde medical technologies, to create a niche in the market. These innovative medical technologies represent the pinnacle of advancements in the medical field aimed at refining patient outcomes, elevating care standards, and endorsing enhanced health. As an example, Gleneagles Hospital, a company based in Malaysia offering medical and healthcare services, unveiled its Nuclear Medicine Unit in August 2023. This nuclear medicine unit is a tailor-made facility situated within a hospital or medical center that is armed with the most recent technology and manned by highly proficient professionals. The mission of this facility is to offer early detection, diagnosis, and curative treatment of diseases through nuclear medicine imaging techniques.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/nuclear-medicine-diagnostics-global-market-report

Which Regions Are Driving Growth in the Nuclear Medicine Diagnostics Market?

North America was the largest region in the nuclear medicine diagnostics market in 2024. The regions covered in the nuclear medicine diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9415

This Report Delivers Insight On:

1. How big is the nuclear medicine diagnostics market, and how is it changing globally?

2. Who are the major companies in the nuclear medicine diagnostics market, and how are they performing?

3. What are the key opportunities and risks in the nuclear medicine diagnostics market right now?

4. Which products or customer segments are growing the most in the nuclear medicine diagnostics market?

5. What factors are helping or slowing down the growth of the nuclear medicine diagnostics market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model